Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-Methylphenylamino)-5-Methyl-Npropylpyrrolo[1,2-F][1,2,4] Triazine-6-Carboxamide (Bms-582949), a Clinical P38 Map Kinase Inhibitor for the Treatment of Inflammatory Diseases
Liu, C., Lin, J., Wrobleski, S.T., Lin, S., Hynes, J., Wu, H., Dyckman, A.J., Li, T., Wityak, J., Gillooly, K.M., Pitt, S., Shen, D.R., Zhang, R.F., McIntyre, K.W., Salter-Cid, L., Shuster, D.J., Zhang, H., Marathe, P.H., Doweyko, A.M., Sack, J.S., Kiefer, S.E., Kish, K.F., Newitt, J.A., McKinnon, M., Dodd, J.H., Barrish, J.C., Schieven, G.L., Leftheris, K.
J.Med.Chem.